PURPOSE: To investigate the role of myeloid-derived suppressor cells (MDSCs) during sepsis in mice. MDSCs are a heterogeneous population of cells that expand during cancer, inflammation and infection. These cells, by their ability to suppress T lymphocyte proliferation, regulate immune responses during various diseases. Their role during microbial infections is scarcely known. METHODS: Septic shock was induced by caecal ligation and puncture in adult male BALB/c mice; sham-operated animals served as controls. Animals were killed under anaesthesia to harvest blood and organs. RESULTS: Polymicrobial sepsis induced a progressive accumulation of MDSCs in spleens that were found to be enlarged in surviving mice. MDSCs harvested at day 10 after the onset of infection were highly responsive to LPS in terms of cytokines secretion, NF-kB activation, ROS production and arginase I activity, whereas early-appearing (day 3) MDSCs poorly responded to this stimulus. By contrast, both day 3 and day 10 MDSCs were able to inhibit T cell proliferation. Adoptive transfer of day 10 MDSCs to septic mice attenuated peritoneal cytokine production, increased bacterial clearance and dramatically improved survival rate. CONCLUSION: These results provide new information on the role of MDSCs, suggesting a protective effect during sepsis. Pharmacologic agents known to promote the expansion of MDSCs should thus be further studied for sepsis treatment.
PURPOSE: To investigate the role of myeloid-derived suppressor cells (MDSCs) during sepsis in mice. MDSCs are a heterogeneous population of cells that expand during cancer, inflammation and infection. These cells, by their ability to suppress T lymphocyte proliferation, regulate immune responses during various diseases. Their role during microbial infections is scarcely known. METHODS: Septic shock was induced by caecal ligation and puncture in adult male BALB/c mice; sham-operated animals served as controls. Animals were killed under anaesthesia to harvest blood and organs. RESULTS: Polymicrobial sepsis induced a progressive accumulation of MDSCs in spleens that were found to be enlarged in surviving mice. MDSCs harvested at day 10 after the onset of infection were highly responsive to LPS in terms of cytokines secretion, NF-kB activation, ROS production and arginase I activity, whereas early-appearing (day 3) MDSCs poorly responded to this stimulus. By contrast, both day 3 and day 10 MDSCs were able to inhibit T cell proliferation. Adoptive transfer of day 10 MDSCs to septic mice attenuated peritoneal cytokine production, increased bacterial clearance and dramatically improved survival rate. CONCLUSION: These results provide new information on the role of MDSCs, suggesting a protective effect during sepsis. Pharmacologic agents known to promote the expansion of MDSCs should thus be further studied for sepsis treatment.
Authors: Alex G Cuenca; Matthew J Delano; Kindra M Kelly-Scumpia; Claudia Moreno; Philip O Scumpia; Drake M Laface; Paul G Heyworth; Philip A Efron; Lyle L Moldawer Journal: Mol Med Date: 2010-11-12 Impact factor: 6.354
Authors: Matthew J Delano; Terri Thayer; Sonia Gabrilovich; Kindra M Kelly-Scumpia; Robert D Winfield; Philip O Scumpia; Alex G Cuenca; Elizabeth Warner; Shannon M Wallet; Mark A Wallet; Kerri A O'Malley; Reuben Ramphal; Michael Clare-Salzer; Philip A Efron; Clayton E Mathews; Lyle L Moldawer Journal: J Immunol Date: 2010-11-24 Impact factor: 5.422
Authors: Veronica Munera; Petar J Popovic; Jodie Bryk; John Pribis; David Caba; Benjamin M Matta; Mazen Zenati; Juan B Ochoa Journal: Ann Surg Date: 2010-01 Impact factor: 12.969
Authors: Matthew J Delano; Philip O Scumpia; Jason S Weinstein; Dominique Coco; Srinivas Nagaraj; Kindra M Kelly-Scumpia; Kerri A O'Malley; James L Wynn; Svetlana Antonenko; Samer Z Al-Quran; Ryan Swan; Chun-Shiang Chung; Mark A Atkinson; Reuben Ramphal; Dmitry I Gabrilovich; Wesley H Reeves; Alfred Ayala; Joseph Phillips; Drake Laface; Paul G Heyworth; Michael Clare-Salzler; Lyle L Moldawer Journal: J Exp Med Date: 2007-06-04 Impact factor: 14.307
Authors: Juan C Mira; Lori F Gentile; Brittany J Mathias; Philip A Efron; Scott C Brakenridge; Alicia M Mohr; Frederick A Moore; Lyle L Moldawer Journal: Crit Care Med Date: 2017-02 Impact factor: 7.598
Authors: Clara McClure; Laura Brudecki; Donald A Ferguson; Zhi Q Yao; Jonathan P Moorman; Charles E McCall; Mohamed El Gazzar Journal: Infect Immun Date: 2014-06-30 Impact factor: 3.441
Authors: Nima Aghaeepour; Cindy Kin; Edward A Ganio; Kent P Jensen; Dyani K Gaudilliere; Martha Tingle; Amy Tsai; Hope L Lancero; Benjamin Choisy; Leslie S McNeil; Robin Okada; Andrew A Shelton; Garry P Nolan; Martin S Angst; Brice L Gaudilliere Journal: J Immunol Date: 2017-08-09 Impact factor: 5.422
Authors: Thomas Rimmelé; Didier Payen; Vincenzo Cantaluppi; John Marshall; Hernando Gomez; Alonso Gomez; Patrick Murray; John A Kellum Journal: Shock Date: 2016-03 Impact factor: 3.454